replica health

What replica health does

Replica Health is an AI/ML research lab founded in 2022 that builds technology for Type 1 Diabetes management. Its core consumer product is an iOS app that integrates continuous glucose monitor (CGM), insulin pump, Apple Health, and geolocation data to model individual carbohydrate absorption patterns and predict glycemic outcomes, reducing guesswork in mealtime insulin dosing. The app features AI-powered carb absorption modeling, metabolic event summaries, chat-based data exploration, automated habit recognition, and provider collaboration tools, and is currently distributed in a beta / limited-release state via the iOS App Store under a freemium model.

The company complements its consumer product with a portfolio of open research assets: MetaboNet, described as the largest publicly available consolidated dataset for Type 1 Diabetes management; GluPredKit, an open-source Python package for blood glucose prediction benchmarking published in the Journal of Open Source Software; and a harmonization framework published in Data in Brief. These research outputs are accompanied by conference participation at venues such as ADA 86th Scientific Sessions 2026 and NIKT 2024.

On the commercial side, Replica operates a B2B motion targeting medical device companies, pharmaceutical firms, and medical data companies through API access, bespoke software components, and clinical trial data collection services enabled by its iOS app. Named enterprise and academic partners include Tidepool, Stanford University, and MannKind, the latter focused on AI-driven drug delivery algorithms. Revenue mechanics span consumer subscriptions (pricing undisclosed), enterprise professional services, and licensing/OEM arrangements for integration with insulin delivery systems. The company is privately held with 1-10 employees and a registered legal entity (Replica Health Co.) in New York, operating from Wilmington, VT.

Name

replica health

Legal name

Replica Health Co.

Website

https://replica.health

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Replica Health is an AI/ML research lab founded in 2022 that builds a Type 1 Diabetes management iOS app and open research tooling (MetaboNet dataset, GluPredKit Python package) integrating CGM, insulin pump, and Apple Health data to model individual carb absorption and support medical device, pharma, and academic partners.

Ownership category

akta.pro rank

Product category

Diabetes Management Software

NAICS

Custom Computer Programming Services (541511)

akta.pro primary industry

Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)

akta.pro secondary industries

Automated Insulin Delivery (AID) / Closed-Loop Systems (HLAHAHAF), Healthcare & Wellness Personalization (HDAAAGAI)

Keywords

• Diabetes management software
• AI carb absorption
• Continuous glucose monitoring
• Blood glucose prediction
• Clinical trial data collection

Headquarters

HQ city

Remote

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. iOS App (Direct-to-Consumer): AI-powered diabetes management app distributed via the iOS App Store, likely with a freemium or subscription model for individual consumers with Type 1 diabetes. The app is described as being in 'limited release, beta version' per the Terms of Service.
2. B2B Research & Data Services: Independent R&D lab services for medical device companies, pharmaceutical companies, and medical data companies. Replica offers unparalleled data collection capabilities for clinical trials via its iOS app, generating revenue through research partnerships and professional services.
3. API Access & Bespoke Software Components: API access and custom software components provided to medical device and pharmaceutical companies for metabolic analysis integration into their own products.
4. Carb Absorption Modeling for Insulin Delivery Systems: AI-powered carb absorption estimates designed for direct integration with insulin delivery systems, likely monetized through technology licensing or OEM-style agreements with device manufacturers.

Pricing tiers

Go-to-market motion4 records

Distribution channels3 records

Marketing channels6 records

Core offering

Replica Health builds an AI-powered iOS application that integrates continuous glucose monitor (CGM), insulin pump, Apple Health, and geolocation data to model personal carbohydrate absorption patterns for Type 1 diabetes patients. The platform provides metabolic event summaries, chat-based data analysis, automated habit recognition, and provider collaboration tools to optimize mealtime insulin dosing. The company also monetizes its underlying ML technology, dataset (MetaboNet), and tooling (GluPredKit) through B2B APIs, clinical trial data collection services, and licensing to medical device and pharmaceutical companies.

Product overview

Replica Health is an AI/ML research lab offering an integrated product ecosystem for diabetes management. The core offering is the Replica Health iOS App, which provides AI-powered carb absorption modeling and integrates with CGM devices, insulin pumps, and Apple Health. The company operates as both a product company (iOS app with Carb Absorption Modeling) and an open research organization, providing research tools including MetaboNet (public diabetes dataset), GluPredKit (Python standardization package), and Harmonizing Diabetes Management Datasets. Enterprise services include API access and clinical trial data collection capabilities for medical device and pharmaceutical companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Replica Health iOS App AI-powered diabetes management iOS application that reveals personal carb absorption patterns to help Type 1 diabetes patients manage blood glucose at mealtime, integrating CGM, insulin pump, Apple Health, and location data.
• Carb Absorption Modeling AI-powered carb absorption estimates designed for direct integration with insulin delivery systems to optimize automated insulin delivery for medical device and pharmaceutical partners.
• MetaboNet The largest publicly available consolidated dataset for Type 1 Diabetes research, used for insulin-dependent diabetes algorithm development and standardization.
• GluPredKit Open-source Python package that standardizes the training, testing, and comparison of blood glucose prediction algorithms, with modular architecture, CLI, and comprehensive documentation.
• Integration Services (B2B API & Bespoke Software Components) API access and bespoke software components provided to medical device and pharmaceutical companies for metabolic analysis integration into their own products.
• Clinical Trial Data Collection Services Unparalleled data collection capabilities for use in clinical trials via Replica's iOS App, available to medical device companies, medical data companies, and pharmaceutical companies.

Quantifiable outcome

• Repeated meals with approximate carb-counting led to better glycemic outcomes for automated insulin delivery users (study with Stanford University and Tidepool)
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability6 records

Feature7 records

Partnerships

Four partnerships are on record, tiered core and minor.

• TidepoolcoreStrategic or Co-development Partner · 5 June 2026Replica Health collaborated with Tidepool and Stanford University on a clinical study demonstrating that repeated meals with approximate carb-counting led to better glycemic outcomes for automated insulin delivery users. This partnership positions Replica as a trusted research partner in the diabetes data ecosystem alongside Tidepool's nonprofit diabetes technology platform.
• Stanford UniversitycoreStrategic or Co-development Partner · 5 June 2026Stanford University collaborated with Replica Health and Tidepool on a study showing that personalized meal records and repeated meals improve glycemic control for automated insulin delivery users even with approximate carb counting. This academic partnership validates Replica's research capabilities and generates peer-reviewed evidence.
• MannKindcoreStrategic or Co-development PartnerMannKind, a pharmaceutical company focused on diabetes and other serious chronic conditions, partners with Replica to develop better drug delivery algorithms using AI. This collaboration leverages Replica's metabolic analysis capabilities and AI/ML expertise to improve MannKind's drug delivery systems.
• ŌURAminorStrategic or Co-development PartnerŌURA is a partner in Tidepool's landmark women's health initiative focused on building the largest opt-in dataset of biometric and diabetes device data. Replica's involvement in this initiative connects it to ŌURA through the Tidepool collaboration.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• One Drop: AI-powered diabetes management platform with CGM integration and predictive glucose insights for both T1D and T2D users. Direct competitor in AI-driven personalized diabetes insights.
• mySugr (Roche): Consumer diabetes management app (acquired by Roche) with CGM and insulin pump integration, carb logging, and bolus advice. Closest direct competitor to Replica's consumer iOS app for T1D mealtime insulin decisions.
• Tidepool: Nonprofit diabetes data platform offering Tidepool Loop (DIY AID system) and a consolidated diabetes dataset. Direct collaborator and functional peer in collecting and standardizing T1D device data for research and patient use.
• Glucose Buddy: Long-standing diabetes tracking app with CGM integration, meal logging, and bolus calculation — overlapping consumer T1D functionality with Replica's app.
• Sugarmate (Tandem Diabetes Care): T1D companion app originally acquired by Tandem that visualizes CGM data and integrates insulin pump data, comparable to Replica's consumer-facing visualization and analytics layer.

Emerging players

• Twin Health: AI platform for Type 2 diabetes management using continuous data from wearables. Comparable in applying AI/ML to personalized metabolic insights, though focused on T2D rather than T1D.
• xDrip: Open-source CGM data collection and visualization tool widely used in the T1D DIY community. Comparable open-source ethos to Replica's GluPredKit and represents the alternative path for technical T1D users.
• Virta Health: AI-driven diabetes reversal platform primarily focused on Type 2 diabetes. Shares the AI-personalization thesis and has employed one of Replica's engineers; competes for adjacent metabolic-condition mindshare.

Broad incumbents

• Dexcom: Largest CGM manufacturer globally with the Dexcom Clarity analytics platform. Owns the primary data source Replica analyzes and could vertically integrate AI dose-decision features that compete with Replica's offering.
• Tandem Diabetes Care: Major insulin pump manufacturer with t:slim X2 AID system and embedded AI-driven insulin automation. Represents the incumbent device-side route by which Replica's AI could be embedded or displaced.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/replica-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about replica health